Enter your email to receive a free trial:
1The Philips Institute of Oral and Craniofacial Molecular Biology, Virginia Commonwealth University
Enter your email to receive a free trial:
An efficient genome-wide single gene mutation method has been established using Streptococcus sanguinis as a model organism. This method has achieved via high throughput recombinant PCRs and transformations.
Ge, X., Xu, P. Genome-wide Gene Deletions in Streptococcus sanguinis by High Throughput PCR. J. Vis. Exp. (69), e4356, doi:10.3791/4356 (2012).
Transposon mutagenesis and single-gene deletion are two methods applied in genome-wide gene knockout in bacteria 1,2. Although transposon mutagenesis is less time consuming, less costly, and does not require completed genome information, there are two weaknesses in this method: (1) the possibility of a disparate mutants in the mixed mutant library that counter-selects mutants with decreased competition; and (2) the possibility of partial gene inactivation whereby genes do not entirely lose their function following the insertion of a transposon. Single-gene deletion analysis may compensate for the drawbacks associated with transposon mutagenesis. To improve the efficiency of genome-wide single gene deletion, we attempt to establish a high-throughput technique for genome-wide single gene deletion using Streptococcus sanguinis as a model organism. Each gene deletion construct in S. sanguinis genome is designed to comprise 1-kb upstream of the targeted gene, the aphA-3 gene, encoding kanamycin resistance protein, and 1-kb downstream of the targeted gene. Three sets of primers F1/R1, F2/R2, and F3/R3, respectively, are designed and synthesized in a 96-well plate format for PCR-amplifications of those three components of each deletion construct. Primers R1 and F3 contain 25-bp sequences that are complementary to regions of the aphA-3 gene at their 5' end. A large scale PCR amplification of the aphA-3 gene is performed once for creating all single-gene deletion constructs. The promoter of aphA-3 gene is initially excluded to minimize the potential polar effect of kanamycin cassette. To create the gene deletion constructs, high-throughput PCR amplification and purification are performed in a 96-well plate format. A linear recombinant PCR amplicon for each gene deletion will be made up through four PCR reactions using high-fidelity DNA polymerase The initial exponential growth phase of S. sanguinis cultured in Todd Hewitt broth supplemented with 2.5% inactivated horse serum is used to increase competence for the transformation of PCR-recombinant constructs. Under this condition, up to 20% of S. sanguinis cells can be transformed using ~50 ng of DNA. Based on this approach, 2,048 mutants with single-gene deletion were ultimately obtained from the 2,270 genes in S. sanguinis excluding four gene ORFs contained entirely within other ORFs in S. sanguinis SK36 and 218 potential essential genes. The technique on creating gene deletion constructs is high throughput and could be easy to use in genome-wide single gene deletions for any transformable bacteria.
1. Primer Design
2. High-throughput PCR Amplification and Purification
3. Competent Cells Preparation
4. Cell Transformation and Antibiotic Selection
5. Mutant Confirmation and Storage
After PCR amplification using primers F1 and R1, and F3 and R3, approximately 1-kb upstream and downstream of each S. sanguinis gene were obtained in 96-well format, respectively (Figure 2A). Under our PCR conditions and using designed primers, a specific product was amplified from S. sanguinis genomic DNA in each PCR reaction. This result indicated the primers were highly specific to the targets of S. sanguinis. Through PCR re-amplification using primers F1 and R3 and three amplicons as DNA templates, linear recombinant PCR constructs (~3 kb) were high-throughput created on 96-well plate, composed of a region upstream of the each target gene, a kanamycin cassette, and a region downstream of each target gene in that order (Figure 2B). The recombinant PCR constructs were then transformed into S. sanguinis SK36 and selected by kanamycin on BHI agar plate. For the majority of transformations, over 1000 colonies were obtained on each plate following a microaerobic 2 d-incubation. When these colonies were PCR-amplified using F1 and R3, a single DNA band corresponding to the expected mutant size (~3 kb) was observed by gel electrophoresis (Figure 2C). When attempting to delete potential essential genes, no colonies could be obtained in the majority of transformations. For deletion of some essential genes, however, colonies were still obtained following transformation. After PCR amplification of these colonies using F1/R3, two DNA bands corresponding to the expected mutant size and the wild type size appeared as revealed by gel electrophoresis (Figure 2C). For some mutants, the expected mutant size and the wild type size of PCR amplicon were too close to be separated by long agarose gel. In this case, an internal primer T1 was designed based upon the wild-type gene sequence. PCR was performed using the internal T1 primer and F1 primer (Figure 2D). The wild-type SK36 was used as a positive control strain for this PCR. If a band with the expected size was amplified from the mutant using the internal primer, the gene was identified as essential gene (double-band mutant) since the presence of kanamycin cassette in the mutant was confirmed previously by DNA sequencing using the P1 primer. Based on this protocol, we eventually collected 2048 non-essential S. sanguinis gene mutants excluding those four ORFs contained entirely within other ORFs (Table 1). We identified 218 genes which are essential for S. sanguinis survival under the experimental conditions.
|Class||Open-reading frames (ORF)|
|Nonessential (promoterless aphA-3)||1973|
|Nonessential (promoter aphA-3)||75|
|Essential (no transformant)||60|
*Four ORFs contained entirely within other ORFs.
Table 1. S. sanguinis gene mutant summary.
Figure 1. Recombinant PCR. Three sets of primers (F1/R1, F2/R2 and F3/R3) are designed to amplify the upstream sequence, a drug resistance gene (Kmr) and the downstream sequence, respectively. Both 5' ends of R1 and F3 primers contain sequences complementary with the cassette of an antibiotic resistant gene. A final PCR recombinant DNA product containing the antibiotic selection marker flanked with S. sanguinis genomic DNA is produced using F1/R3. The recombinant DNA will be integrated into S. sanguinis genome via double cross-over recombination.
Figure 2. Representative gel electrophoresis of PCR amplicons on agarose. A, 1-kb PCR amplicons of upstream or downstream of the target S. sanguinis genes. B, the PCR recombinant DNAs composed of upstream and downstream of the target genes and promoterless aphA-3. C, colony-PCR amplicons from the transformation of S. sanguinis with PCR recombinant DNAs; double bands at lane 4, 10, 14, 15, 20 and 24. D, PCR amplification of wild-type and mutant colonies using primers F1/T1; M, mutant; W, wild-type.
To minimize the possible polar effects of the replacement of one targeted gene with exogenous antibiotics gene on neighboring genes, two steps are taken while initial primer designing. For most of deleted genes, the primers R1 and F3 are designed to delete the coding region from 6 bp following the start codon to 30 bp prior to the stop codon. The last 30 base pairs are retained to protect potential ribosomal binding site used by the adjacent downstream gene. The retained region between two neighboring genes is extended to 100 bp when they were located in opposite orientations and the N-termini of both proteins is close to each other to prevent deleting a potential promoter region. The promoter of aphA-3 gene is excluded in the recombinant construct for gene deletion5. A ribosomal binding site is introduced into the aphA-3 gene for translation. To test our strategy, we randomly constructed 10 and then 96 allelic exchange mutants. We obtained 10 and 93 mutants, respectively, on kanamycin selection plates, suggesting that the promoter-less aphA-3 gene was expressed well in most cases. We then designed and synthesized the primer for promoter-less aphA-3 gene for all gene deletions in the S. sanguinis genome. However, we found some genes in S. sanguinis were low expressed or not expressed which will likely affect the expression of the promoterless aphA-3 gene and hence the kanamycin selection. To solve this issue, the promoter of aphA-3 gene from the plasmid was introduced into the Kmr cassette. A bulk of the promoter Kmr cassette amplicon was obtained from 10 individual PCR using primers F2p/R2. Except that new R1 promoter primers R1p were designed for complement with the promoter Kmr cassette amplicon, all other construction steps were the same as for promoter-less construction.
To improve the efficiency of homologous recombination, we select long (1 kb) flanking sequences upstream and downstream of the S. sanguinis target gene in making gene-deletion constructs. The flanking sequence size was limited to 1 kb on the basis of two points: (1) the DNA fragment length (~3 kb) allowed ready PCR amplification of the aphA-3 gene (~1 kb) plus 2 kb of flanking sequences using high-fidelity DNA polymerase; and (2) the feasibility of sequencing flanking regions by ABI sequencing method from both ends (~1 kb). High numbers of the transformants in the most of S. sanguinis gene deletions indicated 1 kb upstream and downstream sequences, respectively, were enough to knockout the target genes.
To successful connect the upstream and downstream of the target gene with the two ends of aphA-3 gene in PCR recombinant amplification, primers R1, F2, R2 and F3 will be added at their 5' ends an extra sequence that is complementary with the connecting end of the other side in many bacterial gene deletion cases6,7. Preliminary studies showed that the extra sequence could be reduced to 25 bp for this recombinant PCR protocol. In this protocol, we eliminated the extra sequences of primers F2 and R2 in aphA-3 gene and added 25-bp extra sequence to the 5'-end of R1 and F3 in upstream and downstream of the S. sanguinis target gene. This design will decrease the length and amount of primers and hence reduce the cost and the PCR times to improve the efficiency of single-gene deletion. In our laboratory, this design has also been successfully demonstrated for gene deletions in other microbes such as Streptococcus mutans and Streptococcus pneumoniae, and Porphyromonas gingivalis.
In this protocol, the specificity of PCR primers is critical. The primer melting temperature was high (> 58 °C), the primer size was long (>21 bp), and the primer binding site was unique in the genome of S. sanguinis. This design produced single gene-specific products in nearly each of our PCR amplifications. A single gene-specific product from PCR amplification is critical for the last PCR amplification. Otherwise, the final PCR amplification that results in the formation of the final recombinant composed of each gene's upstream and downstream regions and antibiotic gene cassette, respectively, would be difficult.
Cell-density dependence of transformation has been demonstrated in many streptococci such as S. sanguinis8, S. mutans9and S. pneumoniae10. When cell density of S. sanguinis reached an OD660 of 0.07-0.08 (corresponding to ~5x106 CFU/ml) in TH+HS medium, the highest transformation efficiency of S. sanguinis with a linear recombinant PCR amplicon was obtained and up to 20% of S. sanguinis cells could be transformed. After completion of genome-wide gene deletions in S. sanguinis, we found that the number of the transformants for deletion of some nonessential genes was low (~10). There is no doubt that high transformation efficiency of bacteria is important to fulfill all of nonessential gene deletions in the genome-wide gene knockouts.
Except for recombinant construct creation by PCR, there are also other techniques for single gene inactivation. For example, suicide plasmid creation has been extensively applies to inactivate bacterial genes on a small scale. However, this technique has not been used for genome-wide single gene inactivation because large-scale plasmid creation is much time-consuming and laborious, and some bacteria need to be created specific suicide plasmid. Although marker-less gene deletion may avoid the possible polar effect of the antibiotic resistance gene, traditional marker-less gene deletion method is more time-consuming and difficult to inactivate a gene than the suicide plasmid method. In Escherichia coli, genome-wide mark-less gene deletions have been obtained through replacement with antibiotic resistance gene and then elimination of the resistance cassette6. However, this E. coli strain requires the phage λ Red recombinase. Before gene-deletion transformation, the Red helper plasmid pKD46 should be introduced into E. coli11. In our technique, we eliminated the promoter of aphA-3 resistance gene in the vast majority of gene-deleted mutants and designed the two-ends of aphA-3 ORF to follow the expression structure of the gene-deleted region, to avoid the polar effect issue of the resistance cassette. Up to now, we have not found the polar effect issue after examining the function of many mutants created by this technology. A genome-wide and clear set of essential genes acquired in S. sanguinis using this technique12 also imply low possibility of the polar effect of antibiotic cassette in the system. We have demonstrated other promoter-less antibiotic resistance genes, such as erythromycin and chloramphenicol resistance genes, could be applied in this technique (data not shown). In addition, this technique does not need suicide plasmid and reconstructed host. Overall, this technique is high throughput to create genome-wide gene deletion constructs and could be easy to perform in genome-wide single gene mutation of a bacterium.
No conflicts of interest declared.
This work was supported by grants R01DE018138 from the National Institutes of Health (PX) and in part, by Virginia Commonwealth University Presidential Research Incentive Program (PRIP) 144602-3 (PX). We thank Drs. Lei Chen, Yuetan Dou and Xiaojing Wang for assisting with the construction of genome wide mutants. We also thank the DNA Core Facility at Virginia Commonwealth University for DNA sequencing.
|Primer F2||Integrated DNA Technologies||TGACTAACTAGGAGGAATAAATG
|Primer 5' end_R1_seq||ibid||GCCATTTATTCCTCCTAGTTAGTCA|
|Primer 5' end_F3_seq||ibid||GTTTTAGTACCTGGAGGGAATAATG|
|Primer 5' end_R1p_seq||ibid||CCTCAAATGGTTCGCTGGGTTTATC|
|DNA Polymerase||Invitrogen||11304-102||Platinum Taq DNA Polymerase High Fidelity|
|EcoRI||New England Biolabs Inc||R0101S||Restriction enzyme|
|BHI||BD Biosciences||237500||Brain Heart Infusion|
|Horse serum||Fisher Scientific||SH3007403||Horse serum|
|TH broth||BD Biosciences||249240||Todd Hewitt broth|
|PureLink 96||Invitrogen||K310096||PureLink 96 PCR purification kit|
|QIAquick||Qiagen||28106||QIAquick PCR purification kit|
|Filter||Corning||431117||0.22 μm polystyrene filter|
|Anoxomat System||Mart Microbiology b.v.||Anoxomat Mark II|
|Benchtop centrifuge||Thermo Scientific||75004377||Sorvall Legend RT Plus microplate rotor|
|Gel Documentation||UVP LLC||BioDoc-It 210|
|Labnet's Gel XL||Labnet||E0160||Labnet's Gel XL|
|Microcentrifuge||Eppendorf||22621408||Microcentrifuge 5415 R|
|Multichannel pipettes||Thermo Scientfic||4661040, 4661020||Finnpipette F1|
|Thermal Cycler||Applied Biosystems Inc.||N805-0200||GeneAmp PCR system 9700|
You must be signed in to post a comment. Please sign in or create an account.